New research from Dana-Farber Cancer Institute shows that a new class of drug results in cell death in cancers, such as small ...

Financing will enable the completion of the ongoing Phase 1/2 clinical trial of INX-315 in patients with recurrent ...

Scientists have long suspected that stress hormones help fuel the spread of cancer. Now, new research has uncovered how a ...

Incyclix Bio, LLC, a next-generation cell cycle control company developing INX-315, a novel, potent and selective CDK2 inhibitor for the ...

In HPV15-positive first-line recurrent and/or metastatic head and neck cancer, PDS0101 and Keytruda elicited median overall ...

Circadian rhythms regulate the sleep-wake cycle, hormone secretion, metabolism, immune responses, and even patterns of eating and digestion. They help preserve genomic stability, control the cell ...

Newer treatments and expanded screening are allowing more people to live for many years after cancer treatment, a welcome ...